期刊文献+

糖尿病大鼠心肌组织内脏脂肪素的表达及二甲双胍干预作用的观察 被引量:3

The expression of visfatin in myocardium of diabetic rats and the effect of metformin on the expression
原文传递
导出
摘要 目的探讨糖尿病大鼠心肌组织内脏脂肪素(Visfatin)、磷脂酰肌醇酶-3激酶(PI3K)表达及二甲双胍对其干预的作用。方法 60只SD大鼠随机分为正常对照(NC)组、糖尿病(DM)组、二甲双胍治疗(M+DM)组,成模后测定FBG、FIns、FFA、TG、TC、LDL-C,计算胰岛素抵抗指数(HOMA-IR)、ISI;测定心肌Visfatin、PI3K mRNA表达及Visfatin蛋白表达;观察心肌病理变化。结果 DM组FBG、FFA、TG、TC、FIns、HOMA-IR较NC组增高(P<0.05),M+DM组较DM组降低(P<0.05)。DM组心肌组织Visfatin、PI3K mRNA表达较NC组降低(P<0.05),M+DM组心肌组织Visfatin、PI3KmRNA表达均较DM组增高(P<0.05);M+DM组心肌组织Visfatin蛋白表达较DM组增高(P<0.05)。结论二甲双胍可提高糖尿病大鼠心肌组织Visfatin、PI3K表达,对心肌组织保护的作用机制可能是通过调节心肌Visfatin表达水平进而通过PI3K途径完成。 Objective To observe the expressions of visfatin and phosphoinositide 3-kinase (PI3K) in the myocardium of diabetic rats and the their changes of under metformin intervention. Methods Sixty male Sprague-Dawley rats were randomized into the normal control (NC)group, diabetes (DM) group and metformin treatment (M+DM) group. The serum levels of FBG, FFA, TG, TC, LDL-C, and Fins of diabetic models were measured to calculate HOMA-IR and ISI, the expressions of visfatin and PI3K mRNA in the myocardium were determined, the protein expression of visfatin in the myocardium was detected by immunhistochemical stain, and the pathological changes in the myocardium of rats were observed. Results The levels of FBG, FFA, TG, TC, Fins, and HOMA-IR were significantly higher in DM group than in NC group (P〈0. 05), as compared with the DM group, those levels in the M+DM group were decreased (P〈0. 05). The expressions of visfatin and PI3K mRNA in the myocardium was lower in the DM group than in NC group (P〈0. 05) ,and were higher in M+DM than in DM group (P〈 0.05). The expression of visfatin was higher in M+DM group than in DM group (P〈0.05). Conclusion Metformin functions to increase the expressions of visfatin and PI3K in the myocardium of DM rats. Its protective functions for the myocardium are probably realized through regulating the expression of visfatin in the myocardium via the PI3K pathway.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2013年第7期643-646,共4页 Chinese Journal of Diabetes
基金 贵州省优秀科技教育人才省长专项资金项目[黔省专合字(2008)110号] 贵州省科技合作项目[黔科合区域合(2010)7004号]
关键词 糖尿病心肌病 内脏脂肪素 磷脂酰肌醇酶-3激酶 二甲双胍 大鼠 Diabetes eardiomyopathy Visfatin Phosphoinositide 3-kinase(PI3K) Metformin Rats
  • 相关文献

参考文献8

  • 1Hausenloy D, Shiang-Yong L, Paramanathan A, et al. The adipocytokine, visfatin, reduces myocardial infarct size, when given at time of reperfusion, by inhibiting the mitochondrial permeability transition pore. Heart, 2007, 93 : 95-105.
  • 2Choi KM, Kim JH, Cho GJ, et al. Effect of exercise training on plasma visfatin and eotaxin levels. Eur J Endocrinol, 2007, 157:437-442.
  • 3付颖,王丽宏,李强,艾静.内脏脂肪素在糖尿病小鼠心肌中的表达研究[J].中国糖尿病杂志,2010,18(5):373-375. 被引量:1
  • 4Mehta VB, Besner GE. HB-EGF promotes angiogenesis in endothelial cells via PI3-kinase and MAPK signaling pathways. Growth Factors, 2007, 25 : 253-263.
  • 5刘奎,周丽诺,王东,张伟伟,沈晓燕,何岱琨,吴晞,董雪红,杨叶虹,鹿斌,闻杰,胡仁明.磷脂酰肌醇3激酶调节亚基P85α在自发性糖尿病大鼠心肌中表达下降[J].中国糖尿病杂志,2009,17(10):753-755. 被引量:4
  • 6Siragusa M, Katare R, Meloni M, et al. Involvement of phos- phoinositide 3-kinase gamma in angiogenesis and healing of experimental myocardial infarction in mice. Circ Res, 2010, 106: 757-768.
  • 7Adya R, Tan BK, Punn A, et al. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signaling pathways: novel insights into visfatin-induced angiogenesis. Cardiovasc Res, 2008, 8:356-365.
  • 8Ong CR, Molyneaux LM, Constantino MI, et al. Long-term efficacy of metformin therapy in nonobese individuals with type 2 diabetes. Diabetes Care, 2006, 29: 2361-2364.

二级参考文献9

  • 1Witteles RM, Fowler MB. Insulin resistant cardiomyopathy clinical evidence, mechanisms, and treatment options. J Am Coll Cardiol,2008,51:93- 102.
  • 2Takiguchi S, Takata Y, Takahashi N, et al. A disrupted cholecystokinin A receptor gene induces diabetes in obese rats synergistically with ODB1 gene. Am J Physiol, 1998,274 :E265 -E270.
  • 3Dutka DP, Pitt M, Pagano D, et al. Myocardial glucose transport and utilization in patients with type 2 diabetes meliitus, left ventricular dysfunction, and coronary artery disease. J Am Coll Cardiol, 2006,48 : 2225- 2231.
  • 4Kessler A, Uphues I, Ouwens DM, et al. Diversification of cardiac insulin signaling involves the p85 alpha/beta subunits of phosphatidylinositol 3-kinase. Am J Physiol Endoerinol Metab, 2001,280:E65- E74.
  • 5Yu J, Zhang Y, McIlroy J, et al. Regulation of the p85/p110 phosphatidylinositol 3' kinase: stabilization and inhibition of the p110alpha catalytic subunit by the p85 regulatory subunit. Mol Cell Biol, 1998,18 : 1379-1387.
  • 6Fukuhara A,Matsuda M,Nishizawa M,et al.Visfatin:a protein secreted by visceral fat that mimics the effects of insulin.Science,2005,307:426-430.
  • 7Van der Veer E,Nong Z,O 'Neil C,et al.Pre-B-cell colony-enhancing factor regulates NAD+-dependent protein deacetylase astivity and promotes vascular smooth muscle cellmaturation.Circ Res,2005,97:25-34.
  • 8Jia SH,Li Y,Parodo J,et al.Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental in flammation and clinical sepsis.Clin Invest,2004,113:1318-1327.
  • 9Lim SY,Davidson SM,Paramanathan AJ,et al.The novel adipocytokine visfatin exerts direct cardioprotective effects.Cell Mol Med,2008,12:1395-1403.

共引文献3

同被引文献23

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部